In Vitro Activity of Ethanolic Extracts of Vitex doniana Against Multidrug-Resistant Staphylococcus aureus Isolated from Hospital Bed Rails
DOI:
https://doi.org/10.54987/jobimb.v14i1.824Keywords:
Antibiotics, MDRSA, Nosocomial, Resistance, Vitex donianaAbstract
Hospital surfaces serve as reservoirs of pathogens, including multidrug-resistant Staphylococcus aureus (MDRSA), especially in resource-limited areas. This research aims to determine the in vitro activities of Vitex doniana leaf and root extracts on MDRSA isolated from bed rails. Eighty-eight (88) samples were collected from 113 hospital beds and grown on Mannitol Salt Agar at 37oC in 24 hours. Colonies formed were identified morphologically, by Gram-staining, and biochemical characterisation. Antibiotic susceptibility test was performed using Kirby-Bauer technique. The plant extracts were tested against the isolated bacteria through agar well diffusion method. The bacteria were found in 70 samples (79.55%), of which 54 (77.15%) were MDR. A higher percentage of MDRSA was found in the Female Medical and Surgical Wards as well as Male Surgical Wards having 10 (14.29% each), the theatre had the lowest, 1(1.43%). The bacteria were resistant to Ampiclox (69, 98.57%), cefuroxime (69, 98.57%), amoxicillin (65, 92.9%), and ceftriaxone (45, 64.29%). The MICs of the root and leaf extracts were 1.56 mg/mL, and the MBCs were 3.125 mg/mL and 1.56 mg/mL, respectively. Both extracts exhibited antimicrobial activity at 100 mg/mL, 70 mg/mL, and 50 mg/mL concentrations. The mean and standard deviations for 5 replicate assays of the leaf extract indicate that had higher activity (10.50 ± 0.10 - 28.50 ± 0.10 mm) than the root extract (8.50 ±0.10 - 17.50 ± 0.14 mm). High proportion of MDRSA calls for integrated management strategies, including the development and prudent use of potent antimicrobials and disinfection of hospital environments to prevent transmission.
References
1 World Health Organization. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024.
2 Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603-61. https://doi.org/10.1128/CMR.00134-14
3 Morrison L, Zembower TR. Antimicrobial resistance. Gastroint Endosc Clin N Am. 2020;30(4):619-35. https://doi.org/10.1016/j.giec.2020.06.004
4 Minter DJ, Appa A, Chambers HF, Doernberg SB. Contemporary management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2023;77(11):e57-68. https://doi.org/10.1093/cid/ciad500
5 Ibrahim H, Adebayo EA, Olorunfemi ES. Ethnobotanical survey and antimicrobial activity of Vitex doniana (black plum). J Med Plants Res. 2013;7:746-52.
6 Dogara AM, Al-Rawi SS, Hama HA. Traditional uses, bioactive compounds and pharmacological uses of Vitex doniana Sweet: a review. Ethnobot Res Appl. 2025;30:2-130. https://doi.org/10.32859/era.30.12.1-130
7 Islam MT, Ali ES, Uddin SJ, Shaw S, Jahangir MA, Anjum A, et al. Phytochemistry and pharmacological activities of Vitex doniana: a review. Phytother Res. 2024;2:512-30.
8 Salikin NH, Keong LC, Azemin WA, Philip N, Yusuf N, Daud SA, et al. Combating multidrug-resistant Staphylococcus aureus infection using terpenes and their derivatives. World J Microbiol Biotechnol. 2024;40:402. https://doi.org/10.1007/s11274-024-04190-w
9 Ryan TP. Sample size determination and power. Hoboken (NJ): John Wiley & Sons; 2013. https://doi.org/10.1002/9781118439241
10 Cheesbrough M. District laboratory practice in tropical countries. Part 2. 2nd ed. Cambridge: Cambridge University Press; 2006. https://doi.org/10.1017/CBO9780511543470
11 Adetutu AA, Oritsewehinmi B, Ikhiwili MO, Moradeke OA, Odochi SA, Adeola EO. Studies on Staphylococcus aureus isolated from pimples. Pak J Biol Sci. 2017;20:350-4. https://doi.org/10.3923/pjbs.2017.350.354
12 Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Wayne (PA): Clinical and Laboratory Standards Institute; 2026.
13 Mostafa AA, Al-Askar AA, Almaary KS, Dawoud TM, Sholkamy EN, Bakri MM. Antimicrobial activity of some plant extracts against bacterial strains causing food poisoning diseases. Saudi J Biol Sci. 2018;25(2):361-6. https://doi.org/10.1016/j.sjbs.2017.02.004
14 Muthoni SM. Antibiotic susceptibility patterns of bacteria isolated from hospital surfaces and environments in Kenya. Microbiol Res J Int. 2021;31(5):44-55. https://doi.org/10.9734/mrji/2021/v31i530319
15 Omololu-Aso J, Bankole A, Omololu OO, Adesunloro O. Staphylococcus associated with environmental fomites at Ile-Ife, Osun State, Nigeria. Int J Med Sci Acad Res. 2022;3:5-14.
16 Vigny NN, Shu BF. Bacterial profiles and antimicrobial susceptibility patterns of isolates from beds and door handles in hospital wards in the Tiko Health District, Cameroon. Pan Afr Med J. 2024;49:1-12. https://doi.org/10.11604/pamj.2024.49.85.41817
17 Al-Fawares O, Bashabsheh RHF, Natsheh IY, Aburayyan W. Molecular investigation of Staphylococcus aureus isolated from inanimate surfaces in Jordanian hospitals. Braz J Biol. 2024;84:1-10. https://doi.org/10.1590/1519-6984.285397
18 Udobi CE, Obajuluwa AF, Onaolapo JA. Prevalence and antibiotic resistance pattern of methicillin-resistant Staphylococcus aureus from an orthopaedic hospital in Nigeria. Biomed Res Int. 2013;2013:860467. https://doi.org/10.1155/2013/860467
19 Nandkishor B, Yogendra S, Gulshan B, Kohle M. MRSA in hospital settings. In: One health approach-advancing global health security with the Sustainable Development Goals. London: IntechOpen; 2024. p. 1-12.
20 Nadege LDA, Kemayou CKS, Bouopda R, Flora CNM, Laure PM, Cindy LYT, et al. Bacterial ecology and antibiotic susceptibility profile of strains isolated from surfaces and medical devices in selected departments of the Jordan Medical Services, Cameroon: a descriptive cross-sectional study. PAMJ One Health. 2023;11. https://doi.org/10.11604/pamj-oh.2023.11.6.38513
21 Fishovitz J, Hermoso JA, Chang M, Mobashery S. Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. IUBMB Life. 2014;66(8):572-7. https://doi.org/10.1002/iub.1289
22 Adeiza SS, Onaolapo JA, Olayinka BO. Prevalence, risk factors and antimicrobial susceptibility profile of methicillin-resistant Staphylococcus aureus isolated from the nares of patients and staff at state-owned hospitals in Sokoto, Nigeria. GMS Hyg Infect Control. 2020;15:Doc25. https://doi.org/10.2139/ssrn.3704683
23 Gamuya E, Salum MS, Augustino B, Minja B, Damiano P, Mtemisika CI, et al. Contamination of hospital surfaces by third-generation cephalosporin-resistant Gram-negative bacteria in district hospitals in Mwanza, Tanzania: urgent need for enhanced infection prevention and control. Infect Prev Pract. 2025;7:100475. https://doi.org/10.1016/j.infpip.2025.100475
24 Okojokwu OJ, Mawak JD, Lawrence N, Cirfat NA, Shaibu AM, Ndubuisi JC, et al. Burden of rifampicin resistance in methicillin-resistant Staphylococcus aureus among apparently healthy students at the University of Jos, Nigeria. J Health Sci Res. 2023;8:51-6. https://doi.org/10.25259/JHSR_12_2023
25 Hamid N, Ali U, Awan A. Isolation and identification of hospital-environment bacteria associated with healthcare-associated infections in Islamabad, Pakistan. J Community Med Public Health Rep. 2023;4:1-10.
26 Agu CC, Aaron SZ, Akinseye JF, Eya CP, Ogunfolakan OO, Egbebi AH, et al. Bacterial isolation, identification and antibiogram of frequently used fomites in a tertiary hospital in Ado-Ekiti, Ekiti State, Nigeria. Niger Health J. 2024;24:1799-809.
27 Dagnaw M, Belete A, Wondu B, Lulie S, Admassu B, Zemene M, et al. Systematic review and meta-analysis of Staphylococcus aureus at the human-animal-environment interface in Eastern Africa: prevalence, virulence genes and antimicrobial resistance profile. One Health. 2025;21:101229. https://doi.org/10.1016/j.onehlt.2025.101229
28 Garba S, Yakubu IKE, Busayo OO, Fathuddin MM, Obidah SJ, James CI, et al. Incidence of multidrug-resistant Staphylococcus aureus among clinical isolates in the Zaria metropolitan area of Kaduna State, Nigeria. Afr J Pharm Res Dev. 2024;16:19-34. https://doi.org/10.59493/ajopred/2024.2.3
29 Adhikari P, Basyal D, Rai JR, Bharati L, Budthapa A, Gharti KP, et al. Prevalence, antimicrobial susceptibility pattern and multidrug resistance of methicillin-resistant Staphylococcus aureus isolated from clinical samples at a tertiary-care teaching hospital: a cross-sectional study from Nepal. BMJ Open. 2023;13:e067384. https://doi.org/10.1136/bmjopen-2022-067384
30 Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of pathogens on inanimate surfaces and implications for infection control. J Hosp Infect. 2020;104(3):246-51. https://doi.org/10.1016/j.jhin.2020.01.022
31 Samuel KE, Abraham GA, Alizaga SA. Antimicrobial activities of black plum (Vitex doniana Sweet) leaf and stem-bark extracts against selected clinical pathogens. Int J Res Phys Stud. 2025;9:1-10. https://doi.org/10.70382/nijhrps.v9i3.008
32 Ali MM, Mudi SY. Phytochemical and antibacterial properties of Vitex doniana (black plum) leaf extracts: insight from chloroform and n-hexane fractions. Niger Res J Chem Sci. 2025;13:477-86.
33 Bittner S, Müller P. Antibacterial activity of medicinal plants and their constituents in the context of skin and wound infections, considering European legislation and folk medicine: a review. Int J Mol Sci. 2021;22(19):10746. https://doi.org/10.3390/ijms221910746
34 Irampagarikiye R, Abdallah A, Diouara M, Thiam F, Momar C. Vitex doniana Sweet: applications and therapeutic potential-a scoping review. Discov Appl Sci. 2025;7:1-11. https://doi.org/10.1007/s42452-025-06581-6
35 Ogunleye BO, Oshamika OO, Akinpelu SO, Ajayi AS, Akinduti PA, Oyedeji KS, et al. Prevalence and associated risk factors of Staphylococcus aureus nasal colonization among a cohort of immunocompromised individuals in Lagos, Nigeria. BMC Infect Dis. 2025;25:1-9. https://doi.org/10.1186/s12879-025-12416-x
36 Parusnath M, Naidoo Y, Singh M, Hassan YD, Kianersi F. Antioxidant and antibacterial activities of leaf and stem extracts of Combretum molle (R. Br. ex G. Don) Engl. & Diels. Plants (Basel). 2023;12. https://doi.org/10.3390/plants12091757
37 Asghar MU, Zhai Y, Liu T, Fan P, Ain NU, Zaidi AH, et al. A metagenomics-based approach to understanding the transmission of healthcare-associated antimicrobial resistance in Pakistan. J Hazard Mater. 2025;496:139384. https://doi.org/10.1016/j.jhazmat.2025.139384
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Surajo Wada Adamu, Ibrahim Alhaji Sabo, Samuel Tamuno Brown, Faith Akyara, Miracle Gomnati

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).